BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
일요일, 9월 27

Tenet Healthcare Corp

THCNYSE
Trade with Public
Trade with Public
$259.71
10.174.08%
가까이에: Sep 25, 5:00 PM EST
$259.71
N/A
시간외: Sep 25, 4:00 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교주식 보고서

Tenet Healthcare Financials

Tenet Healthcare (THC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade

Tenet Healthcare lifted its 2026 outlook after beating Q2 estimates, citing hospital growth, expense control and M&A momentum.
Vandana Singh

PRO
Tenet Healthcare Raises FY2026 GAAP EPS Guidance from $22.94-$32.64 to $34.57-$36.43 vs $24.76 Est

Tenet Healthcare (NYSE:THC) raises FY2026 GAAP EPS guidance from $22.94-$32.64 to $34.57-$36.43 vs $24.76 analyst estimate..
Benzinga Newsdesk

PRO
Tenet Healthcare Raises FY2026 Adj EPS Guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 Est; Raises FY2026 Sales Guidance from $21.500B-$22.300B to $21.900B-$22.500B vs $21.996B Est

Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $16.38-$18.68 to $20.30-$21.69 vs $17.88 analyst estimate. Raises FY2026 sales outlook from $21.500 billion-$22.300 billion to $21.900 billion-$22.500
Benzinga Newsdesk

PRO
Tenet Healthcare Q2 Adj. EPS $6.12 Beats $4.23 Estimate, Sales $5.628B Beat $5.430B Estimate

Tenet Healthcare (NYSE:THC) reported quarterly earnings of $6.12 per share which beat the analyst consensus estimate of $4.23 by 44.68 percent. This is a 52.24 percent increase over earnings of $4.02 per share from the
Benzinga Newsdesk

Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales

Tenet Healthcare posts Q1 earnings beat but revenue miss as payer mix shifts and external disruptions weigh on performance.
Vandana Singh

Earnings Scheduled For April 30, 2026

Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved